Tyvaso 64 MCG kit
Ended Awarded
- Contract number
- 36C24526N0311
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $17,352
Award facts
- Contract value 100% obligated
- $17,351.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
United Therapeutics Corp has been awarded a delivery order valued at $17,351.60 by Veterans Integrated Service Network 5 (VISN 5) for Tyvaso 64 microgram inhalation kits, with an ultimate completion date of February 13, 2026. This is a firm fixed-price delivery order with no set-aside designation, executed under the General Services Administration's Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB). The product will be delivered to a facility in Bartlett, Tennessee, and represents part of the Department of Veterans Affairs' ongoing efforts to ensure reliable access to specialized medications for treating pulmonary arterial hypertension and related conditions affecting the veteran population.
This delivery order operates under a larger single-award Blanket Purchase Agreement between United Therapeutics and the VA National Acquisition Center, valued at $207.1 million and effective through April 23, 2026. Under this BPA structure, VISN 5 and other Veterans Integrated Service Networks nationwide can issue delivery orders directly to United Therapeutics for four critical pharmaceutical products: Unituxin, Remodulin, Tyvaso, and Orenitram. United Therapeutics, a biotechnology manufacturer headquartered in Silver Spring, Maryland, specializes in treatments for rare and life-threatening medical conditions and serves as a significant supplier of specialized pharmaceutical products to the federal government, with the VA as its primary customer.
Quick answers
Who was awarded contract 36C24526N0311?
36C24526N0311 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 10, 2026.
How much is contract 36C24526N0311 worth?
The government has obligated $17,352 on 36C24526N0311.
Is contract 36C24526N0311 an order under another contract?
Yes. 36C24526N0311 is a delivery order under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0311 competed?
The extent of competition for 36C24526N0311 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award